$580 million EU antitrust fine for drug makers

The European Union's antitrust body is imposing a fine of 428 million euros ($580 million) on France's pharmaceutical company Servier and five producers of generic medicines for distorting competition.

The 28-nation bloc's executive Commission on Wednesday said Servier struck a series of deals with the producers of to protect its bestselling blood pressure medicine, Perindopril, from .

EU competition chief Joaquin Almunia says Servier's practices of "systematically buying out any competitive threats" to protect its market was "clearly anti-competitive and abusive."

The Commission says Servier must pay a fine of 331 million euros ($450 million). The remaining fine of about 100 million euros is split between the five producers of generic medicines according to the extent of their involvement. They are Niche/Unichem, Matrix, Teva, Krka and Lupin.


Explore further

EU to slap big fine on French drugmaker Servier: sources

© 2014 The Associated Press. All rights reserved.

Citation: $580 million EU antitrust fine for drug makers (2014, July 9) retrieved 2 July 2020 from https://medicalxpress.com/news/2014-07-million-eu-antitrust-fine-drug.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments